Healthinvest Partners AB Form 13-G Filed 2006-11-27
|
OMB
APPROVAL
|
|
OMB
Number: 3235-0145
|
|
Expires:
February 28, 2009
|
|
Estimated
average burden
hours
per response 10.4
|
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the
Securities Exchange Act of 1934
(Amendment
No. __)*
Bio-Imaging
Technologies, Inc.
-------------------------------------------------------------------------------
(Name
of
Issuer)
Common
Stock
-------------------------------------------------------------------------------
(Title
of
Class of Securities)
09056N103
--------------------------------------------
(CUSIP
Number)
November
15, 2006
-------------------------------------------------------------------------------
(Date
of
Event Which Requires Filing of this Statement)
Check
the
appropriate box to designate the rule pursuant to which this Schedule is
filed:
[_]
Rule
13d-1(b)
[X]
Rule
13d-1(c)
[_]
Rule
13d-1(d)
*The
remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed
to
be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934
("Act") or otherwise subject to the liabilities of that section of the Act
but
shall be subject to all other provisions of the Act (however, see the
notes).
Persons
who respond to the collection of information contained in this form are not
required to respond unless the form displays a currently valid OMB control
number.
SEC
1745
(3-06)
-----------------------------------
CUSIP
No.
09056N103
-----------------------------------
----------------------------------------------------------------------------------------------------
1. Names
of
Reporting Persons
I.R.S.
Identification Nos. of above persons (entities only)
Healthinvest
Partners AB
-----------------------------------------------------------------------------------------------------
2. Check
the
Appropriate Box if a Member of a Group (See Instructions)
(a)
[ ]
(b)
[X]
-----------------------------------------------------------------------------------------------------
3. SEC
Use
Only
-----------------------------------------------------------------------------------------------------
4. Citizenship
or Place of Organization
Sweden
-----------------------------------------------------------------------------------------------------
Number
of 5. Sole
Voting Power
645,374
Shares -------------------------------------------------------------------------
Beneficially 6. Shared
Voting Power
0
Owned
by -------------------------------------------------------------------------
Each 7. Sole
Dispositive Power 645,374
Reporting -------------------------------------------------------------------------
Person
With: 8. Shared
Dispositive Power
0
----------------------------------------------------------------------------------------------------
9. Aggregate
Amount Beneficially Owned by Each Reporting Person
645,374
----------------------------------------------------------------------------------------------------
10. Check
if
the Aggregate Amount in Row (9) Excludes Certain Shares
(See
Instructions) [
]
----------------------------------------------------------------------------------------------------
11. Percent
of Class Represented by Amount in Row (9)
5.7%
----------------------------------------------------------------------------------------------------
12. Type
of
Reporting Person (See Instructions)
IA,
HC
----------------------------------------------------------------------------------------------------
-----------------------------------
CUSIP
No.
09056N103
-----------------------------------
----------------------------------------------------------------------------------------------------
1. Names
of
Reporting Persons
I.R.S.
Identification Nos. of above persons (entities only)
HealthInvest
Global Long/Short Fund
-----------------------------------------------------------------------------------------------------
2.
Check
the
Appropriate Box if a Member of a Group (See Instructions)
(a)
[ ]
(b)
[X]
-----------------------------------------------------------------------------------------------------
3.
SEC
Use
Only
-----------------------------------------------------------------------------------------------------
4. Citizenship
or Place of Organization
Sweden
-----------------------------------------------------------------------------------------------------
Number
of 5. Sole
Voting Power 645,374
Shares -------------------------------------------------------------------------
Beneficially 6.
Shared
Voting Power 0
owned
by -------------------------------------------------------------------------
Each
7.
Sole
Dispositive Power 645,374
Reporting -------------------------------------------------------------------------
Person
With: 8.
Shared
Dispositive Power 0
----------------------------------------------------------------------------------------------------
9. Aggregate
Amount Beneficially Owned by Each Reporting Person
645,374
----------------------------------------------------------------------------------------------------
10. Check
if
the Aggregate Amount in Row (9) Excludes Certain Shares
(See
Instructions) [
]
----------------------------------------------------------------------------------------------------
11. Percent
of Class Represented by Amount in Row (9)
5.7%
----------------------------------------------------------------------------------------------------
12. Type
of
Reporting Person (See Instructions)
OO
----------------------------------------------------------------------------------------------------
Item
1(a). Name
of
Issuer:
Bio-Imaging
Technologies, Inc.
Item
1(b).
Address
of Issuer's Principal Executive Offices:
826
Newtown-Yardley Road
Newtown,
Pennsylvania 18940-1721
Item
2(a). Name
of
Persons Filing:
Healthinvest
Partners AB and HealthInvest Global Long/Short Fund
Healthinvest
Partners AB is the investment advisor and control person of HealthInvest
Global
Short/Long
Fund, a security holder of the Issuer. HealthInvest Global Long/Short Fund
is a
specialty fund organized pursuant to the Swedish Mutual Funds Act.
Item
2(b).
Address
of Principal Business Office or, if none, Residence:
Arsenalsgatan 4
SE-111 47 Stockholm
Sweden
Item
2(c).
Citizenship:
See the response(s) to Item 4 on the attached cover page(s).
Item
2(d).
Title
of
Class of Securities
Common Stock
Item
2(e).
CUSIP
Number:
09056N103
Item
3.
If
this
statement is filed pursuant to Rules 13d-1(b) or 3d-2(b) or (c), check whether
the person filing
is
a:
Not
Applicable
Item
4. Ownership.
(a). Amount
beneficially owned
See
the response(s) to Item 9 on the attached cover page(s).
(b).
Percent
of Class:
See
the response(s) to Item 11 on the attached cover page(s).
(c). Number
of
shares as to which the person has:
(i). Sole
power to vote or to direct the vote: See the response(s) to Item 5 on the
attached cover
page(s).
(ii). Shared
power to vote or to direct the vote: See the response(s) to Item 6 on the
attached
cover page(s).
(iii). Sole
power to dispose or to direct the disposition of: See the response(s) to Item
7on
the
attached cover page(s).
(iv). Shared
power to dispose or to direct the disposition of: See the response(s) to Item
8
on
the
attached cover page(s).
Item
5.
Ownership
of five percent or less of a class.
Not
Applicable
Item
6.
Ownership
of more than five percent on behalf of another person.
Not
Applicable
Item
7.
Identification
and Classification of the Subsidiary which acquired the Security being reported
on by
the
Parent Holding Company.
Not
Applicable
Item
8. Identification
and Classification of Members of the Group.
Not
Applicable
Item
9. Notice
of
Dissolution of Group.
Not
Applicable
Item
10.
Certification.
By
signing below I certify that, to the best of my knowledge and belief, the
securities referred to
above
were not acquired and are not held for the purpose of or with the effect of
changing or
influencing
the control of the issuer of the securities and were not acquired and are not
held in
connection
with or as a participant in any transaction having that purpose or
effect.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that
the information set forth in this statement is true, complete and
correct.
Date: November
27, 2006
HEALTHINVEST
PARTNERS AB
By:
/s/
ANDERS HALLBERG
--------------------------------------------------
Name: Anders
Hallberg
Title: Managing
Director and CEO
HEALTHINVEST
GLOBAL LONG/SHORT FUND
/s/
ANDERS HALLBERG
-------------------------------------------------
Name: Anders
Hallberg
Title: CEO
of
Managing Company